logo

Search

Login | Create Account

oncology


Categories

Blood Breast cancer Cancer care Childhood cancers End-of-life care Endocrine GI cancer GU cancer Head and neck cancer Lung cancer Medicines Medicopolitical Melanoma Podcasts Radiation oncology Research Risk Factors Sarcoma

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

ESMO Breast Cancer 2021

Wednesday 5th - Saturday 8th May 2021

ESMO Breast Cancer Virtual Congress 2021

Breast cancer

ESMO 2021: Instability in HER2 expression over disease progression opens up treatment options

HER2-low expression is highly unstable during breast cancer evolution suggesting that biopsies of locoregional relapses or distant metastases might reveal potentially new therapeutic opportunities for some patients, research suggests. Presenting at ESMO Breast Cancer 2021, Dr Federica Miglietta said access to...

HER2-low expression is highly unstable during breast cancer evolution suggesting that biopsies of locoregional relapses or distant metastases might reveal...


Cancel
Cancel